Traduction de «substantial increase » (Néerlandais → Français) :

TERMINOLOGIE

substantie | stof
substance | substance

eetbare substantie
substance comestible

aanval met bijtende substantie, met uitzondering van vergiftiging
agression avec une substance corrosive ou caustique, sauf empoisonnement

aanval met bijtende substantie met uitzondering van vergiftiging
agression avec une substance corrosive, sauf empoisonnement

aanval door bijtende substantie
agression avec une substance caustique

blootstelling aan mogelijk gevaarlijke substantie
exposition à une substance potentiellement dangereuse

Belgische simpele referentieset voor vertaalde eetbare substanties
ensemble de référence simple belge pour les substances comestibles traduites

substantie
substance

besmette substantie gebruikt voor vaccinatie
substance contaminée utilisée pour un vaccin

allergie voor substantie
allergie à une substance

TRADUCTIONS EN CONTEXTE

This resulted in a substantial increase in the tax rate to 16.3% for the second quarter of 2009 compared to 13.0% in the year-ago period.
Il en est résulté, au deuxième trimestre 2009, une hausse substantielle du taux d’imposition à 16,3%, par rapport à 13,0% un an auparavant.

EFSA - European Food Safety Authority. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.
linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.

This release contains forward-looking information that involves substantial risks and uncertainties concerning the possibility of future dividend increases. Such risks and uncertainties include, among other things, the Company’s future financial performance as well as general economic, political, business, industry, regulatory and market conditions.
Such risks and uncertainties include, among other things, the Company’s future financial performance as well as general economic, political, business, industry, regulatory and market conditions.